Dr. Watson has extensively published and presented about her areas of pharmacy practice expertise. Please explore some selected publications and presentations below.
Summers KM, Watson K, Michocki R. Hypertensive Crisis In Koda-Kimble MA, Young LY, Kradjan WA et al., editors: Applied Therapeutics: Clinical Use of Drugs, 9th Ed. Lippincott Williams and Wilkins. 2008, p20-1 to 20-19. Invited, reviewed. ISBN 0781765552
Summers KM, Watson K. Drug-induced cardiovascular disease. In: Crouch MA, editor. Cardiovascular pharmacotherapy: a point-of-care guide. 1st ed. Bethesda, Maryland: American Society of Health-System Pharmacists;2010:p 29-62. Invited, reviewed. ISBN 9781585282159
Watson K, Watson BD, Summers KM, Michocki R. Hypertensive Crisis In Koda-Kimble MA, Young LY, Kradjan WA et al., editors: Applied Therapeutics: Clinical Use of Drugs, 10th Ed. Lippincott Williams and Wilkins. Invited, reviewed. ISBN 9781609137137
Watson K, Walker CL. Strategies for Preparing for a Multi-program Residency Accreditation Visit. Am J Health Syst Pharm 2016;73:614 and 616.
|Grover BE, Hayes BD, Watson K. Feedback in Clinical Pharmacy Education. Am J Health Syst Pharm 2014;71:1592-96.|
Touissant KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and Factors that Influence Board Certification Among Pharmacy Practice Faculty at US Schools/Colleges of Pharmacy. Pharmacotherapy. 2013;33:105-111.
Pincus K, Tata A, Watson K. The risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis. Annals of Pharmacotherapy. 2012;46:873-78.
Devabhakthuni S, Pajoumand M, Williams C, Watson K, Kufera JA, Stein D. Evaluation of Dexmedetomidine: Safety and Clinical Outcomes in Critically Ill Trauma Patients. J Trauma 2011;71164-71.
Knapp EM, Watson K. Medication Management of Atrial Fibrillation: Emerging Therapies for Rhythm Control and Stroke Prevention. P and T Journal 2011;36:2-15.
Summers KM, Martin K, Watson K. Impact and Clinical Management of Depression in Patients with Coronary Artery Disease Pharmacotherapy 2010; 30:304-322.
Watson K, Summers KM. Depression in Patients with Heart Failure: Clinical Implications and Management Pharmacotherapy 2009;13:49-63.
Watson K, Seybert AL, Saul MI, Lee JL, Kane-Gill SL. A Comparison of Outcomes for Patients Receiving Bivalirudin and Unfractionated Heparin in Percutaneous Coronary Intervention Pharmacotherapy 2007;27:647-56.
Physical Assessment Training for Pharmacy Residents and Fellows: A Focus on the Cardiovascular Exam. Watson K, Leon N, Devabhakthuni S. ASHP National Pharmacy Preceptors Conference, August 2016.
Evaluation of Qtc Interval in Hospitalized Patients Receiving Methadone. Palasik BN, Devabhakthuni S, Reed BN, Watson K. 49th ASHP Midyear Clinical Meeting and Exhibition, December 2014.
Using Google Services as an Innovative Educational Tool for Advanced Pharmacy Practice Experience Rotations. Watson K, Devabhathuni S. American College of Clinical Pharmacy Virtual Symposium, April 2013.
Time of Income Receipt and Effects on Heart Failure Exacerbations during the Course of a Month. Simon C, Hynicka L, Watson K, Onukwugha E. Poster Presentation, American Society of Health System Pharmacists, 47th Midyear Clinical Meeting, December 2012.
Support for Pharmacy Residency Programs at a Large Academic Institution: the Role of a Residency and Academic Coordinator. Watson K, Kendall MD, Trovato JA. Poster Presentation, American Society of Health System Pharmacists National Residency Preceptor Conference, August 2012.
Attempting to be a Little Less PC; Design and Implementation of a Preceptor Development Program at a Large Academic Campus. Watson K, Grover BE, Wilson SL, Kendall MD, McPherson ML. Poster Presentation, American Society of Health System Pharmacists National Residency Preceptor Conference, August 2012.
Teaching Certificate Program at the University of Maryland. Poster Presentation, American Society of Health System Pharmacists, 46th Midyear Clinical Meeting, December 2011.